Clinical Trials Directory

Trials / Unknown

UnknownNCT04310683

Natural Cycle or Stimulated Cycle Versus Hormone Replaced Cycle for Pre-eclampsia Rate

The Live Birth Rate in Natural Cycle or Stimulated Cycle Versus Hormone Replaced Cycle in Patients Undergoing Frozen-thawed Embryo Transfer

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
840 (estimated)
Sponsor
Women's Hospital School Of Medicine Zhejiang University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Recent sutdies indicate that the existence of corpus lutein in the ovary is a key point to prevent preeclampsia, and patients undergoing FET with hormone replaced cycle have no corpus lutein and the absence of corpus lutein significantly increases the risk of preeclampsia in these patients. We aim to conduct a single center randomized trial study to compare the preeclampsia rate between the natural cycle and the hormone replaced cycle in patients undergoing FET.

Conditions

Interventions

TypeNameDescription
OTHERnatural cycle for endometrium preparationpatients will not use oral contraceptive drugs
OTHERhormone replaced cycle for endometrium preparationpatients will receive oral contraceptive drugs for menstruation before embryo transfer

Timeline

Start date
2020-11-10
Primary completion
2021-12-10
Completion
2022-03-10
First posted
2020-03-17
Last updated
2020-03-17

Source: ClinicalTrials.gov record NCT04310683. Inclusion in this directory is not an endorsement.